GL1X · GenesisL1 explorer

MolNFT v1 · #186525 · protein

Human retinal variant IMPDH1(546) treated with GTP, ATP, imp, NAD+; interface-centered

7RGQ: “Human retinal variant IMPDH1(546) treated with GTP, ATP, imp, NAD+; interface-centered”. Electron microscopy, 4 ligands (GTP, NAD, IMP). MolNFT v1 #186525 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7RGQ
Type
protein
Length
3,848 residues
Chains
8
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P20839
Ligands
GTP, NAD, IMP, ATP

Structure

electron microscopy · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, F, G, H—protein481—P20839

Ligands and binding sites

  • GTP · Guanosine-5'-triphosphate · ligand · 16 copies · chains A, B, C, D, E, F, G, H
  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 8 copies · chains A, B, C, D, E, F, G, H
  • IMP · Inosinic acid · ligand · 8 copies · chains A, B, C, D, E, F, G, H
  • ATP · Adenosine-5'-triphosphate · ligand · 8 copies · chains A, H, B, G, C, F, D, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7RGQ · Human retinal variant IMPDH1(546) treated with GTP, ATP, imp, NAD+; interface-centered · the same entry in another collection · chain H against H, TM-score 1.00
  • P20839 · AlphaFold monomer V2.0 prediction for inosine-5'-monophosphate dehydrogenase 1 (P20839) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.